Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract B040: Trispecific killer engagers against IGF1R and fetal form of insulin receptor induce human natural killer cell mediated killing of hormone receptor positive breast cancer in vitro and in vivo

Courtney Baar, Emily Chiu, Yvette Soignier, Behiye Kodal, Jeffrey S Miller, Martin Felices, Deepali Sachdev

Cancer Res (2024) 84 (3_Supplement_1): B040.

https://doi.org/10.1158/1538-7445.ADVBC23-B040

Published: 01 February 2024

View article titled, Abstract B040: Trispecific killer engagers against IGF1R and fetal form of insulin receptor induce human natural killer cell mediated killing of hormone receptor positive breast cancer in vitro and in vivo

Journal Articles

Abstract P5-04-11: Targeting hormone receptor positive breast cancer for immune destruction by natural killer cells

Emily Chiu, Ivy R Johnson, Jeffrey S Miller, Martin Felices, Deepali Sachdev

Cancer Res (2020) 80 (4_Supplement): P5-04-11.

https://doi.org/10.1158/1538-7445.SABCS19-P5-04-11

Published: 15 February 2020

View article titled, Abstract P5-04-11: Targeting hormone receptor positive breast cancer for immune destruction by natural killer cells

Journal Articles

Abstract 949: Progesterone receptor/IRS-1 cooperation promotes stem cell outgrowth and endocrine resistance in estrogen receptor-positive luminal breast cancer

Amy R. Dwyer, Deepali Sachdev, Carol A. Lange

Cancer Res (2018) 78 (13_Supplement): 949.

https://doi.org/10.1158/1538-7445.AM2018-949

Published: 01 July 2018

View article titled, Abstract 949: Progesterone receptor/IRS-1 cooperation promotes stem cell outgrowth and endocrine resistance in estrogen receptor-positive luminal breast cancer

Journal Articles

Abstract 2303: CDK4/6 inhibition blocks effects of IGFs and insulin in estrogen receptor positive and triple negative breast cancers

Katelyn Hoff, Deepali Sachdev

Cancer Res (2018) 78 (13_Supplement): 2303.

https://doi.org/10.1158/1538-7445.AM2018-2303

Published: 01 July 2018

View article titled, Abstract 2303: CDK4/6 inhibition blocks effects of IGFs and insulin in estrogen receptor positive and triple negative breast cancers

Journal Articles

Abstract 4248: Functional imaging markers for blockade of breast cancer metastasis by IGF1R and insulin receptor targeted drugs using novel MRI and targeted iron oxide nanoparticles

Deepali Sachdev, Huy Donguyen, Naoharu Kobayashi, Sidath C. Kumarapperuma, Joeseph C. Weber

Cancer Res (2016) 76 (14_Supplement): 4248.

https://doi.org/10.1158/1538-7445.AM2016-4248

Published: 15 July 2016

View article titled, Abstract 4248: Functional imaging markers for blockade of breast cancer metastasis by IGF1R and insulin receptor targeted drugs using novel MRI and targeted iron oxide nanoparticles

Journal Articles

Abstract P1-07-03: Dual inhibition of IGF1R and insulin receptor in estrogen receptor positive and triple negative breast cancer and monitoring blockade of metastasis using novel MRI

Deepali Sachdev, Joel D Winer, Naoharu Kobayashi, Michael Garwood, Joseph Weber

Cancer Res (2015) 75 (9_Supplement): P1-07-03.

https://doi.org/10.1158/1538-7445.SABCS14-P1-07-03

Published: 01 May 2015

View article titled, Abstract P1-07-03: Dual inhibition of IGF1R and insulin receptor in estrogen receptor positive and triple negative breast cancer and monitoring blockade of metastasis using novel MRI

Journal Articles

Abstract 1327: IGF-I and insulin signaling enhances levels of choline kinase in breast cancer cells: Implications for developing noninvasive magnetic resonance spectroscopy of choline containing compounds as a biomarker of response to IGF1R targeted therapy.

Huy T. Donguyen, Joseph C. Weber, Deepali Sachdev

Cancer Res (2013) 73 (8_Supplement): 1327.

https://doi.org/10.1158/1538-7445.AM2013-1327

Published: 15 April 2013

View article titled, Abstract 1327: IGF-I and insulin signaling enhances levels of choline kinase in breast cancer cells: Implications for developing noninvasive magnetic resonance spectroscopy of choline containing compounds as a biomarker of response to IGF1R targeted therapy.

Journal Articles

Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment

Dedra H. Fagan, Ryan R. Uselman, Deepali Sachdev, Douglas Yee

Cancer Res (2012) 72 (13): 3372–3380.

https://doi.org/10.1158/0008-5472.CAN-12-0684

Published: 01 July 2012

View article titled, Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment

Journal Articles

Abstract 2288: CYP3A4 monoxygenase regulates IGF-1 signaling in ER-positive breast cancer cells

Zhijun Guo, Ranjana Mitra, Monica Milani, Mariangellys Rodriguez, Douglas Yee, Deepali Sachdev, David A. Potter

Cancer Res (2011) 71 (8_Supplement): 2288.

https://doi.org/10.1158/1538-7445.AM2011-2288

Published: 15 April 2011

View article titled, Abstract 2288: CYP3A4 monoxygenase regulates IGF-1 signaling in ER-positive breast cancer cells

Journal Articles

Abstract 3295: The type I insulin-like growth factor receptor (IGF1R) pathway driven metastasis signature correlates with poor prognosis and decreased distant metastasis-free survival in human breast cancer

Deepali Sachdev, Aaron Sarver

Cancer Res (2010) 70 (8_Supplement): 3295.

https://doi.org/10.1158/1538-7445.AM10-3295

Published: 15 April 2010

View article titled, Abstract 3295: The type I insulin-like growth factor receptor (IGF1R) pathway driven metastasis signature correlates with poor prognosis and decreased distant metastasis-free survival in human breast cancer

Journal Articles

Non-invasive MRS monitoring of response to anti-IGF1R therapy in breast cancer

Deepali Sachdev, Joseph E. Lin, Evin H. Gulbahce, Michael G. Garwood, Douglas Yee

Cancer Res (2006) 66 (8_Supplement): 235.

Published: 15 April 2006

View article titled, Non-invasive MRS monitoring of response to anti-IGF1R therapy in breast cancer

Journal Articles

Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti–Insulin-Like Growth Factor Therapy in Breast Cancer

Deepali Sachdev, Rajeeva Singh, Yoko Fujita-Yamaguchi, Douglas Yee

Cancer Res (2006) 66 (4): 2391–2402.

https://doi.org/10.1158/0008-5472.CAN-05-3126

Published: 17 February 2006

View article titled, Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti–Insulin-Like Growth Factor Therapy in Breast Cancer

Journal Articles

A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I

Deepali Sachdev, Shu-Lian Li, Julie S. Hartell, Yoko Fujita-Yamaguchi, Jeffrey S. Miller, Douglas Yee

Cancer Res (2003) 63 (3): 627–635.

Published: 01 February 2003

View article titled, A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I

NARROW

Abstract B040: Trispecific killer engagers against IGF1R and fetal form of insulin receptor induce human natural killer cell mediated killing of hormone receptor positive breast cancer in vitro and in vivo

Abstract P5-04-11: Targeting hormone receptor positive breast cancer for immune destruction by natural killer cells

Abstract 949: Progesterone receptor/IRS-1 cooperation promotes stem cell outgrowth and endocrine resistance in estrogen receptor-positive luminal breast cancer

Abstract 2303: CDK4/6 inhibition blocks effects of IGFs and insulin in estrogen receptor positive and triple negative breast cancers

Abstract 4248: Functional imaging markers for blockade of breast cancer metastasis by IGF1R and insulin receptor targeted drugs using novel MRI and targeted iron oxide nanoparticles

Abstract P1-07-03: Dual inhibition of IGF1R and insulin receptor in estrogen receptor positive and triple negative breast cancer and monitoring blockade of metastasis using novel MRI

Abstract 1327: IGF-I and insulin signaling enhances levels of choline kinase in breast cancer cells: Implications for developing noninvasive magnetic resonance spectroscopy of choline containing compounds as a biomarker of response to IGF1R targeted therapy.

Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment

Abstract 2288: CYP3A4 monoxygenase regulates IGF-1 signaling in ER-positive breast cancer cells

Abstract 3295: The type I insulin-like growth factor receptor (IGF1R) pathway driven metastasis signature correlates with poor prognosis and decreased distant metastasis-free survival in human breast cancer

Non-invasive MRS monitoring of response to anti-IGF1R therapy in breast cancer

Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti–Insulin-Like Growth Factor Therapy in Breast Cancer

A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only